NYU Langone Health has opened a state-of-the-art, comprehensive Inflammatory Bowel Disease Center that brings together all elements of care for adult patients with Crohn’s disease and ulcerative colitis.
The newly designed 12,500-square-foot outpatient care center located at 305 East 33rd Street, has 9 exam rooms and a 6-bay infusion center, providing the capacity to care for more than 100 patients daily.
Inflammatory bowel disease, or IBD, is a condition in which there is chronic or recurring inflammation in the digestive tract, causing symptoms of abdominal pain, diarrhea, constipation, and fatigue. The two most common types of IBD are Crohn’s disease and ulcerative colitis.
“We’ve always offered multidisciplinary care for our patients with IBD, taking care of both their physical and mental wellbeing,” says David P. Hudesman, MD, associate professor of medicine and co-director of the Inflammatory Bowel Disease Center. “Our new center enables us to provide world-class care in a convenient setting with staff who understand the nuances of treating IBD.”
A complex and often lifelong condition, IBD affects more than one million individuals in the United States, who often require several physicians and other medical professionals to manage their care. The multidisciplinary team of renowned experts at NYU Langone’s Inflammatory Bowel Disease Center provide advanced treatment including the following:
- gastroenterology services
- colon and rectal surgery consultations and postoperative care
- infusion treatments
- nutritional services and support
- ostomy care
- psychosocial care and support groups
- access to novel clinical trials
“Multispecialty centers also foster collaboration among providers, enhancing our ability to provide exceptional care,” says Feza Remzi, MD, professor of surgery and director of the Inflammatory Bowel Disease Center. “Our entire IBD team works together tirelessly to ensure each of our patients will have a great future.”